Category: Company News

Cardiff Lexington reported lower year-to-date revenue and a near-breakeven adjusted EBITDA result for the first half of 2026, as weaker realization rates on patient case settlements and working capital constraints offset growth in new patients and surgical procedures. Key Investor Takeaways Why CDIX Stock Is in Focus Cardiff Lexington’s second-quarter filing highlights a divergence between…

Valion Bio is moving into a near-term government-funded Entolimod study programme evaluating protection against lethal radiation-induced gastrointestinal injury, with safety dosing planned to begin this week and top-line therapeutic data anticipated in early fall. Key Investor Takeaways Why VBIO Stock Is in Focus Valion Bio’s Entolimod programme is approaching an important experimental stage as AFRRI…

Capstone Holding reported 67% year-over-year revenue growth in the second quarter of 2026, while Stone Business Adjusted EBITDA reached $2.0 million and turned positive sequentially as previously guided. The building products distributor also reaffirmed its full-year 2026 financial guidance. Key Investor Takeaways Why (NASDAQ:CAPS) Stock Is in Focus Capstone’s second-quarter results showed faster gross profit…

Bone Biologics has extended the validated shelf life of its rhNELL-1 protein to 32 months, giving the company greater manufacturing and supply-chain flexibility as it prepares for larger-scale clinical development and advances enrollment in its first-in-human NB1 study. Key Investor Takeaways Why (NASDAQ:BBLG) Stock Is in Focus Bone Biologics has validated a 32-month shelf life…

Zhibao Technology has signed an agreement with Dongbaohui to establish a joint venture focused on AI-native embedded long-term insurance, adding a new strategic growth initiative alongside its existing 2B2C digital insurance business. Key Investor Takeaways Why ZBAO Stock Is in Focus Zhibao Technology is expanding its business model into long-term insurance through a newly agreed…

SCIENTURE has commercially launched REZENOPY, its 10 mg naloxone nasal spray, and fulfilled initial purchase orders to U.S. pharmaceutical wholesalers, moving its second FDA-approved commercial product into nationwide distribution. Key Investor Takeaways Why SCNX Stock Is in Focus SCIENTURE has fulfilled its first REZENOPY purchase orders to U.S. pharmaceutical wholesalers and commenced nationwide distribution, marking…

Intuit is rolling out Intuit Intelligence Chat and broader AI-powered financial capabilities across QuickBooks Online Advanced and Intuit Enterprise Suite, strengthening its push into more complex mid-market finance workflows. Key Investor Takeaways Why INTU Stock Is in Focus Intuit is expanding Intuit Intelligence across QuickBooks Online Advanced and Intuit Enterprise Suite, with Intuit Intelligence Chat…

HydroGraph is expanding its U.S. production footprint with an Austin headquarters capable of producing up to 30 tons of pristine graphene annually and a larger Bellville facility expected to begin operations in 2027. Key Investor Takeaways Why HGRAF Stock Is in Focus HydroGraph has completed the opening of its Texas headquarters as it advances a…

Anavex is asking shareholders to re-elect its six nominees at the September 24 annual meeting as activist investor PVG seeks board control during a leadership transition and a critical period for the company’s CNS pipeline. Key Investor Takeaways Why AVXL Stock Is in Focus Anavex Life Sciences is heading toward a contested September shareholder vote…

The success-fee engagement is designed to connect 1606 Corp.’s planned Lufkin acquisition with AI infrastructure operators, capacity buyers and potential joint venture partners while the company works toward completing the property transaction. Key Investor Takeaways Why CBDW Stock Is in Focus 1606 Corp. has added MDM Group to its effort to commercialize a planned AI…